Genex Pharmaceutical, Inc.

GENX · OTC
Analyze with AI
12/31/2007
12/31/2006
12/31/2005
12/31/2004
Operating Activities
Net Income$343$619$625$1,013
Dep. & Amort.$56$55$60$59
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$472$500$667-$982
Other Non-Cash$603$6$25$0
Operating Cash Flow$530$1,180$1,377$90
Investing Activities
PP&E Inv.-$1-$4-$1-$6
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1,878-$1,295$0$0
Investing Cash Flow-$1,880-$1,299-$1-$6
Financing Activities
Debt Repay.$0$0-$1,452$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,567$6$37$0
Financing Cash Flow$1,567$6-$1,415$0
Forex Effect$21$8$10$0
Net Chg. in Cash$238-$104-$30$84
Supplemental Information
Beg. Cash$192$296$326$242
End Cash$430$192$296$326
Free Cash Flow$528$1,177$1,376$84